INSIDE BLOOD:
Pumping out platelets
D. B. Cines
p.4591-4592
No more transplantation in CML?
F. Guilhot
p.4592
PD-1_ T cells: exhausted and premature?
L. Su
p.4593-4594
How low can you go: quality effects of an anti-CD4 antibody
E. J. Kim and A. H. Rook
p.4594-4595
Altruistic donor T cells
P. Tiberghien
p.4595
Inhibitors in hemophilia: nature or nurture?
T. Abshire
p.4596
Trading muscle iron for erythropoiesis at high altitude
C. Hershko
p.4597
BLOOD WORK:
Adult T-cell leukemia/lymphoma
p.4598
PLENARY PAPERS:
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
Adrian Wiestner, Mahsa Tehrani, Michael Chiorazzi, George Wright, Federica Gibellini, Kazutaka Nakayama, Hui Liu, Andreas Rosenwald, H. Konrad Muller-Hermelink, German Ott, Wing C. Chan, Timothy C. Greiner, Dennis D. Weisenburger, Julie Vose, James O. Armitage, Randy D. Gascoyne, Joseph M. Connors, Elias Campo, Emilio Montserrat, Francesc Bosch, Erlend B. Smeland, Stein Kvaloy, Harald Holte, Jan Delabie, Richard I. Fisher, Thomas M. Grogan, Thomas P. Miller, Wyndham H. Wilson, Elaine S. Jaffe, and Louis M. Staudt, for the Lymphoma/Leukemia Molecular Profiling Project
p.4599-4606
REVIEW ARTICLES:
New thrombopoietic growth factors
David J. Kuter
p.4607-4616
HOW I TREAT:
How I treat indolent lymphoma
John G. Gribben
p.4617-4626
CHEMOKINES, CYTOKINES, AND INTERLEUKINS:
The peritoneal micromilieu commits B cells to home to body cavities and the small intestine
Simon Berberich, Reinhold Förster, and Oliver Pabst
p.4627-4634.
CLINICAL TRIALS AND OBSERVATIONS:
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA–positive chronic eosinophilic leukemia
Jelena V. Jovanovic, Joannah Score, Katherine Waghorn, Daniela Cilloni, Enrico Gottardi, Georgia Metzgeroth, Philipp Erben, Helena Popp, Christoph Walz, Andreas Hochhaus, Catherine Roche-Lestienne, Claude Preudhomme, Ellen Solomon, Jane Apperley, Michela Rondoni, Emanuela Ottaviani, Giovanni Martinelli, Finella Brito-Babapulle, Giuseppe Saglio, Rüdiger Hehlmann, Nicholas C. P. Cross, Andreas Reiter, and David Grimwade, on behalf of the European LeukemiaNet
p.4635-4640
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study
Henrik Hasle, Todd A. Alonzo, Anne Auvrignon, Catherine Behar, Myron Chang, Ursula Creutzig, Alexandra Fischer, Erik Forestier, Alcira Fynn, Oskar A. Haas, Jochen Harbott, Christine J. Harrison, Nyla A. Heerema, Marry M. van den Heuvel-Eibrink, Gertjan J. L. Kaspers, Franco Locatelli, Peter Noellke, Sophia Polychronopoulou, Yaddanapudi Ravindranath, Bassem Razzouk, Dirk Reinhardt, Natalia N. Savva, Batia Stark, Stefan Suciu, Ichiro Tsukimoto, David K. Webb, Dorora Wojcik, William G. Woods, Martin Zimmermann, Charlotte M. Niemeyer, and Susana C. Raimondi
p.4641-4647
Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study
Samantha C. Gouw, Johanna G. van der Bom, and H. Marijke van den Berg, for the CANAL Study group
p.4648-4654
Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma
Youn H. Kim, Madeleine Duvic, Erik Obitz, Robert Gniadecki, Lars Iversen, Anders Österborg, Sean Whittaker, Timothy M. Illidge, Thomas Schwarz, Roland Kaufmann, Kevin Cooper, Kim M. Knudsen, Steen Lisby, Ole Baadsgaard, and Susan J. Knox
p.4655-4662
Racial variation in the relationship of anemia with mortality and mobility disability among older adults
Kushang V. Patel, Tamara B. Harris, Marion Faulhaber, Sara B. Angleman, Stephanie Connelly, Douglas C. Bauer, Lewis H. Kuller, Anne B. Newman, and Jack M. Guralnik, for the Health, Aging, and Body Composition Study
p.4663-4670
PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors
Ji-Yuan Zhang, Zheng Zhang, Xicheng Wang, Jun-Liang Fu, Jinxia Yao, Yanmei Jiao, Liangen Chen, Hui Zhang, Jianan Wei, Lei Jin, Ming Shi, George Fu Gao, Hao Wu, and Fu-Sheng Wang
p.4671-4678
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia
William G. Wierda, Susan O'Brien, Xuemei Wang, Stefan Faderl, Alessandra Ferrajoli, Kim-Anh Do, Jorge Cortes, Deborah Thomas, Guillermo Garcia-Manero, Charles Koller, Miloslav Beran, Francis Giles, Farhad Ravandi, Susan Lerner, Hagop Kantarjian, and Michael Keating
p.4679-4685
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia
Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann, Hermann Heimpel, Andreas Hochhaus, Joerg Hasford, Hans-Jochem Kolb, Tanja Lahaye, Ole Maywald, Andreas Reiter, Dieter K. Hossfeld, Christoph Huber, Helmut Löffler, Hans Pralle, Wolfgang Queisser, Andreas Tobler, Christoph Nerl, Max Solenthaler, Mariele E. Goebeler, Martin Griesshammer, Thomas Fischer, Stephan Kremers, Hartmut Eimermacher, Michael Pfreundschuh, Wolf-Dietrich Hirschmann, Klaus Lechner, Barbara Wassmann, Christiane Falge, Hartmut H. Kirchner, and Alois Gratwohl, for the Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK) and the German CML Study Group
p.4686-4692.
Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study
Samantha C. Gouw, Johanna G. van der Bom, Günter Auerswald, Carmen Escuriola Ettinghausen, Ulf Tedgård, and H. Marijke van den Berg, for the CANAL Study group
p.4693-4697
GENE THERAPY:
Antitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation
Fabio Ciceri, Chiara Bonini, Sarah Marktel, Elisabetta Zappone, Paolo Servida, Massimo Bernardi, Alessandra Pescarollo, Attilio Bondanza, Jacopo Peccatori, Silvano Rossini, Zulma Magnani, Monica Salomoni, Claudia Benati, Maurilio Ponzoni, Luciano Callegaro, Paolo Corradini, Marco Bregni, Catia Traversari, and Claudio Bordignon
p.4698-4707
The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies
Catia Traversari, Sarah Marktel, Zulma Magnani, Patrizia Mangia, Vincenzo Russo, Fabio Ciceri, Chiara Bonini, and Claudio Bordignon
p.4708-4715
HEMATOPOIESIS:
G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms
Marta Donini, Stefania Fontana, Gianfranco Savoldi, William Vermi, Laura Tassone, Francesca Gentili, Elena Zenaro, Daniela Ferrari, Lucia D. Notarangelo, Fulvio Porta, Fabio Facchetti, Luigi D. Notarangelo, Stefano Dusi, and Raffaele Badolato
p.4716-4723
Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle
Paul Robach, Gaetano Cairo, Cecilia Gelfi, Francesca Bernuzzi, Henriette Pilegaard, Agnese Viganò, Paolo Santambrogio, Paolo Cerretelli, José A. L. Calbet, Stéphane Moutereau, and Carsten Lundby
p.4724-4731
Evidence that the Pim1 kinase gene is a direct target of HOXA9
Yu-Long Hu, Emmanuelle Passegué, Stephen Fong, Corey Largman, and Hugh Jeffrey Lawrence
p.4732-4738
Brief report Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist
Julian M. Jenkins, Daphne Williams, Yanli Deng, Joanne Uhl, Valerie Kitchen, David Collins, and Connie L. Erickson-Miller
p.4739-4741
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY:
Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure
Femke Zwerts, Florea Lupu, Astrid De Vriese, Saskia Pollefeyt, Lieve Moons, Rachel A. Altura, Yuying Jiang, Patrick H. Maxwell, Peter Hill, Hideyasu Oh, Claus Rieker, Désiré Collen, Simon J. Conway, and Edward M. Conway
p.4742-4752
Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion
Jeffrey S. Scehnet, Weidong Jiang, S. Ram Kumar, Valery Krasnoperov, Alexandre Trindade, Rui Benedito, Dusan Djokovic, Cristina Borges, Eric J. Ley, Antonio Duarte, and Parkash S. Gill
p.4753-4760
In vivo vasculogenic potential of human blood-derived endothelial progenitor cells
Juan M. Melero-Martin, Zia A. Khan, Arnaud Picard, Xiao Wu, Sailaja Paruchuri, and Joyce Bischoff
p.4761-4768
Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids
Julia M. Malleier, Olga Oskolkova, Valery Bochkov, Ingrid Jerabek, Barbora Sokolikova, Thomas Perkmann, Johannes Breuss, Bernd R. Binder, and Margarethe Geiger
p.4769-4776
Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment
Stefan Amatschek, Ernst Kriehuber, Wolfgang Bauer, Barbel Reininger, Paul Meraner, Alois Wolpl, Norbert Schweifer, Christian Haslinger, Georg Stingl, and Dieter Maurer
p.4777-4785
Moderation of the platelet releasate response by aspirin
Judith A. Coppinger, Roisin O'Connor, Kieran Wynne, Michelle Flanagan, Matthew Sullivan, Patricia B. Maguire, Desmond J. Fitzgerald, and Gerard Cagney
p.4786-4792
Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells
Tri Minh Bui Nguyen, Indira V. Subramanian, Ameeta Kelekar, and Sundaram Ramakrishnan
p.4793-4802
Brief report
Platelet-bound lipopolysaccharide enhances Fc receptor–mediated phagocytosis of IgG-opsonized platelets
John W. Semple, Rukhsana Aslam, Michael Kim, Edwin R. Speck, and John Freedman
p.4803-4805
Brief report
The novel inhibitory receptor G6B is expressed on the surface of platelets and attenuates platelet function in vitro
Stephen A. Newland, Iain C. Macaulay, Andres R. Floto, Edwin C. de Vet, Willem H. Ouwehand, Nicholas A. Watkins, Paul A. Lyons, and Duncan R. Campbell
p.4806-4809
IMMUNOBIOLOGY:
Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation
Ruth R. French, Vadim Y. Taraban, Graham R. Crowther, Tania F. Rowley, Juliet C. Gray, Peter W. Johnson, Alison L. Tutt, Aymen Al-Shamkhani, and Martin J. Glennie
p.4810-4815
Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors
Pearlie K. Epling-Burnette, Fanqi Bai, Jeffrey S. Painter, Dana E. Rollison, Helmut R. Salih, Matthias Krusch, JianXiang Zou, Edna Ku, Bin Zhong, David Boulware, Lynn Moscinski, Sheng Wei, Julie Y. Djeu, and Alan F. List
p.4816-4824
Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors
Robert S. Welner, Rosana Pelayo, Karla P. Garrett, Xinrong Chen, S. Scott Perry, Xiao-Hong Sun, Barbara L. Kee, and Paul W. Kincade
p.4825-4931
HIV-1–specific CTLs effectively suppress replication of HIV-1 in HIV-1–infected macrophages
Mamoru Fujiwara and Masafumi Takiguchi
p.4832-4838
Bortezomib enhances dendritic cell (DC)–mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications
Radek Spisek, Anna Charalambous, Amitabha Mazumder, David H. Vesole, Sundar Jagannath, and Madhav V. Dhodapkar
p.4839-4845
Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections
Nobuhiro Nakano, Chiharu Nishiyama, Shunsuke Kanada, Yusuke Niwa, Naomi Shimokawa, Hiroko Ushio, Makoto Nishiyama, Ko Okumura, and Hideoki Ogawa
p.4846-4855
T cell–dependent survival of CD20+ and CD20– plasma cells in human secondary lymphoid tissue
David R. Withers, Claudia Fiorini, Randy T. Fischer, Rachel Ettinger, Peter E. Lipsky, and Amrie C. Grammer
p.4856-4864
Adoptive transfer of tumor-primed, in vitro–activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response
Li-Xin Wang, Suyu Shu, Mary L. Disis, and Gregory E. Plautz
p.4865-4876
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency
Roberta Castriconi, Alessandra Dondero, Claudia Cantoni, Mariella Della Chiesa, Carola Prato, Marina Nanni, Maurilia Fiorini, Lucia Notarangelo, Silvia Parolini, Lorenzo Moretta, Luigi Notarangelo, Alessandro Moretta, and Cristina Bottino
p.4873-4881
CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype
Yuwen Zhu, Gefeng Zhu, Liqun Luo, Andrew S. Flies, and Lieping Chen
p.4882-4889
NEOPLASIA:
Monoclonal TCR-Vß13.1+/CD4+/NKa+/CD8–/+dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin
Pilar Garrido, Francisco Ruiz-Cabello, Paloma Bárcena, Yorick Sandberg, Julia Cantón, Margarida Lima, Ana Balanzategui, Marcos González, Miguel Angel López-Nevot, Anton W. Langerak, Andrés C. García-Montero, Julia Almeida, and Alberto Orfao
p.4890-4898
Development of a murine model for blastoid variant mantle-cell lymphoma
Richard J. Ford, Long Shen, Yen Chiu Lin-Lee, Lan V. Pham, Asha Multani, Hai-Jun Zhou, Archito T. Tamayo, ChongJie Zhang, Lesleyann Hawthorn, John K. Cowell, and Julian L. Ambrus, Jr
p.4899-4906
Endogenous bcl-2 is not required for the development of Eµ-myc–induced B-cell lymphoma
Priscilla N. Kelly, Hamsa Puthalakath, Jerry M. Adams, and Andreas Strasser
p.4907-4913
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma
Karène Mahtouk, Dirk Hose, Pierre Raynaud, Michael Hundemer, Michel Jourdan, Eric Jourdan, Veronique Pantesco, Marion Baudard, John De Vos, Marion Larroque, Thomas Moehler, Jean-Francois Rossi, Thierry Rème, Hartmut Goldschmidt, and Bernard Klein
p.4914-4923
The myeloproliferative disorder–associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3
Michelle B. Hookham, Joanne Elliott, Yvonne Suessmuth, Judith Staerk, Alister C. Ward, William Vainchenker, Melanie J. Percy, Mary Frances McMullin, Stefan N. Constantinescu, and James A. Johnston
p.4924-4929
Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy
Heidi Nyman, Magdalena Adde, Marja-Liisa Karjalainen-Lindsberg, Minna Taskinen, Mattias Berglund, Rose-Marie Amini, Carl Blomqvist, Gunilla Enblad, and Sirpa Leppä
p.4930-4935.
p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors
Duonan Yu, Martin Carroll, and Andrei Thomas-Tikhonenko
p.4936-4943
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia
Valerio Fulci, Sabina Chiaretti, Marina Goldoni, Gianluca Azzalin, Nicoletta Carucci, Simona Tavolaro, Leandro Castellano, Armando Magrelli, Franca Citarella, Monica Messina, Roberta Maggio, Nadia Peragine, Simona Santangelo, Francesca Romana Mauro, Pablo Landgraf, Thomas Tuschl, David B. Weir, Minchen Chien, James J. Russo, Jingyue Ju, Robert Sheridan, Chris Sander, Mihaela Zavolan, Anna Guarini, Robin Foà, and Giuseppe Macino
p.4944-4951
The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells
Laurence de Leval, David S. Rickman, Caroline Thielen, Aurélien de Reynies, Yen-Lin Huang, Georges Delsol, Laurence Lamant, Karen Leroy, Josette Brière, Thierry Molina, Françoise Berger, Christian Gisselbrecht, Luc Xerri, and Philippe Gaulard
p.4952-4963
Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenström macroglobulinemia
Anne-Sophie Moreau, Xiaoying Jia, Hai T. Ngo, Xavier Leleu, Garrett O'Sullivan, Yazan Alsayed, Alexey Leontovich, Klaus Podar, Jeffrey Kutok, John Daley, Suzan Lazo-Kallanian, Evdoxia Hatjiharissi, Marc S. Raab, Lian Xu, Steven P. Treon, Teru Hideshima, Kenneth C. Anderson, and Irene M. Ghobrial
p.4964-4972
CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia
Pär Josefsson, Christian H. Geisler, Henrik Leffers, Jørgen H. Petersen, Mette K. Andersen, Jesper Jurlander, and Anne Mette Buhl
p.4973-4979
Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas
Anastasia Pantelias, John M. Pagel, Nathan Hedin, Laura Saganic, Shani Wilbur, Donald K. Hamlin, D. Scott Wilbur, Yukang Lin, Diane Stone, Don Axworthy, Ajay K. Gopal, and Oliver W. Press
p.4980-4987
The mitochondrial effects of novel apoptogenic molecules generated by psoralen photolysis as a crucial mechanism in PUVA therapy
Sergio Caffieri, Fabio Di Lisa, Federico Bolesani, Monica Facco, Gianpietro Semenzato, Francesco Dall'Acqua, and Marcella Canton
p.4988-4994
CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms
Fenghuang Zhan, Simona Colla, Xiaosong Wu, Bangzheng Chen, James P. Stewart, W. Michael Kuehl, Bart Barlogie, and John D. Shaughnessy, Jr
p.4995-5001
CD28-mediated regulation of multiple myeloma cell proliferation and survival
Nizar J. Bahlis, Anne M. King, Despina Kolonias, Louise M. Carlson, Hong Yu Liu, Mohamad A. Hussein, Howard R. Terebelo, Gerald E. Byrne, Jr, Bruce L. Levine, Lawrence H. Boise, and Kelvin P. Lee
p.5002-5010
Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis study
Arghya Ray, Sandra W. Cowan-Jacob, Paul W. Manley, Jürgen Mestan, and James D. Griffin
p.5011-5015
Hsp90 regulates the Fanconi anemia DNA damage response pathway
Tsukasa Oda, Toshiya Hayano, Hidenobu Miyaso, Nobuhiro Takahashi, and Takayuki Yamashita
p.5016-5026
RED CELLS:
Ineffective erythropoiesis in ß-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin
Sara Gardenghi, Maria F. Marongiu, Pedro Ramos, Ella Guy, Laura Breda, Amy Chadburn, YiFang Liu, Ninette Amariglio, Gideon Rechavi, Eliezer A. Rachmilewitz, William Breuer, Z. Ioav Cabantchik, Diedra M. Wrighting, Nancy C. Andrews, Maria de Sousa, Patricia J. Giardina, Robert W. Grady, and Stefano Rivella
p.5027-5035
Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria
Lucia Gargiulo, Sonia Lastraioli, Giannamaria Cerruti, Martina Serra, Fabrizio Loiacono, Simona Zupo, Lucio Luzzatto, and Rosario Notaro
p.5036-5042
STEM CELLS IN HEMATOLOGY:
Steel factor responsiveness regulates the high self-renewal phenotype of fetal hematopoietic stem cells
Michelle B. Bowie, David G. Kent, Michael R. Copley, and Connie J. Eaves
p.5043-5048
TRANSPLANTATION:
Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD
Kelli P. A. MacDonald, Rachel D. Kuns, Vanessa Rowe, Edward S. Morris, Tatjana Banovic, Helen Bofinger, Brendan O'Sullivan, Kate A. Markey, Alistair L. Don, Ranjeny Thomas, and Geoffrey R. Hill
p.5049-5057
Brief report
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT
Jeffery S. Miller, Sarah Cooley, Peter Parham, Sherif S. Farag, Michael R. Verneris, Karina L. McQueen, Lisbeth A. Guethlein, Elizabeth A. Trachtenberg, Michael Haagenson, Mary M. Horowitz, John P. Klein, and Daniel J. Weisdorf
p.5058-5061
CORRESPONDENCE:
Isolated high-molecular-weight kininogen deficiency: a novel frameshift mutation in exon 10
Toshio Shigekiyo, Junko Miyagi, Atsuhisa Shirakami, Hironobu Shibata, Kazuo Tsukai, and Ken-ichi Aihara
p.5062-5063
Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia
Alida Dominietto, Sarah Pozzi, Maurizio Miglino, Flavio Albarracin, Giovanna Piaggio, Francesca Bertolotti, Raffaella Grasso, Simona Zupo, Anna Maria Raiola, Marco Gobbi, Francesco Frassoni, and Andrea Bacigalupo
p.5063-5064
Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sézary syndrome
Anne Marie-Cardine, Delphine Huet, Nicolas Ortonne, Natacha Remtoula, Sabine Le Gouvello, Martine Bagot, and Armand Bensussan
p.5064-5065
|
